CD69 and neoplasm: All constructs were transduced into TCR-deficient Jurkat76 (J76) cells, yielding similar γδTCR surface expression levels (Supplementary Figure 5A), and CD69 upregulation by J76 cells upon co-culture with the tumor cell line Daudi, was used as a marker for TCR-mediated T-cell activation.